Please login to the form below

Not currently logged in

Prosensa Therapeutics

This page shows the latest Prosensa Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Shire rumoured to be pursuing Actelion

Shire rumoured to be pursuing Actelion

Other transactions including rare disease companies of late include Horizon Pharma's $1.1bn deal to buy urea cycle disorder specialist Hyperion Therapeutics and BioMarin $840m purchase of Prosensa in order

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Larry Bell joins Dutch biopharma Prosensa Larry Bell joins Dutch biopharma Prosensa

    Takes up role as head of global regulatory affairs. Dutch biopharmaceutical company Prosensa Therapeutics has appointed Larry Bell as head of global regulatory affairs. ... For his new role at Prosensa, which focuses on RNA-modulating therapeutics for

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....